Sleep-wake architecture in mouse models for Down syndrome

Neurobiology of Disease

Volumn 16, Issue 2, 2004, Pages 291-299

  Colas, Damien ^a   London, Jacqueline ^b   Gharib, Abdallah ^a   Cespuglio, Raymond ^a   Sarda, Nicole ^a  

^a UNIVERSITÉ LYON 1   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

A ; AD; Alzheimer's disease; Amyloid precursor protein; amyloid peptide; APP; central nervous system; CNS; Down syndrome; Down's syndrome; DS; EEG; electroencephalogram; hSOD1; Sleep wake; Superoxide dismutase; Transgenic mice

Indexed keywords

AMYLOID PRECURSOR PROTEIN; COPPER ZINC SUPEROXIDE DISMUTASE; NITRITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DISEASE MODEL; DOWN SYNDROME; ELECTROENCEPHALOGRAM; MOUSE; NONHUMAN; PRIORITY JOURNAL; REM SLEEP; SLEEP DISORDER; SLEEP WAKING CYCLE; SLOW WAVE SLEEP; THETA RHYTHM; TRANSGENIC MOUSE; WAKEFULNESS;

ANIMALS; BRAIN STEM; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; DOWN SYNDROME; MICE; MICE, TRANSGENIC; NITRATES; NITRIC OXIDE; NITRITES; SLEEP; SLEEP DISORDERS, CIRCADIAN RHYTHM; SUPEROXIDE DISMUTASE; WAKEFULNESS;

EID: 2942585187     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2004.03.009     Document Type: Article

References (60)

1. Andreou G., Galanopoulou C., Gourgoulianis K., Karapetsas A., Molyvdas P. Cognitive status in Down syndrome individuals with sleep disordered breathing deficits (SDB). Brain Cogn. 50:2002;145-149
2. Antonarakis S.E., Lyle R., Chrast R., Scott A. Differential gene expression studies to explore the molecular pathophysiology of Down syndrome. Brain Res. Rev. 36:2001;265-274
3. Avraham K.B., Sugarman H., Rotshenker S., Groner Y. Down's syndrome: morphological remodelling and increased complexity in the neuromuscular junction of transgenic CuZn-superoxide dismutase mice. J. Neurocytol. 20:1991;208-215
4. Borbély A. A two process model of sleep regulation. Hum. Neurobiol. 1:1982;195-204
5. Borg J., London J. Copper/zinc superoxide dismutase overexpression promotes survival of cortical neurons exposed to neurotoxins in vitro. J. Neurosci. Res. 70:2002;180-189
6. Burlet S., Léger L., Cespuglio R. Nitric oxide and sleep in the rat: a puzzling relationship. Neuroscience. 92:1999;627-639
7. Caviedes P., Ault B., Rapoport S.I. The role of altered sodium currents in the action potential abnormalities of cultured dorsal root ganglion neurons from trisomy 21 (Down's syndrome) human fetuses. Brain Res. 510:1990;229-236
8. Chan P.H., Chu L., Chen S.F., Carlson E.J., Epstein C.J. Attenuation of glutamate-induced neuronal swelling and toxicity in transgenic mice overexpressing human Cu/Zn-superoxide dismutase. Acta Neurochir., Suppl. 51:1990;245-247
9. Ciriolo M.R., De Martino A., Lafavia E., Rossi L., Carry M.T., Rotilio G. Cu, Zn - Superoxide dismutase-dependent apoptosis induced by nitric oxide in neuronal cells. J. Biol. Chem. 275:2000;5065-5072
10. Clément P., Gharib A., Cespuglio R., Sarda N. Changes in the sleep-wake cycle architecture and cortical nitric oxide release during ageing in the rat. Neuroscience. 116:2003;863-870
11. Cortas N.K., Wakid N.W. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin. Chem. 36:1990;1440-1443
12. Dierssen M., Fillat C., Crnic L., Arbones M., Florez J., Estivill X. Murine models for Down syndrome. Physiol. Behav. 73:2001;859-871
13. Dijk D.J., Edgar D.M. Circadian and homeostatic control of wakefulness and sleep. Turek F.W., Zee P.C. Regulation of sleep and circadian rhythms. vol. 133:1999;111-148 Marcel Dekker Inc, New York
14. Diomedi M., Curatola P., Scalise A., Pacidi F., Caretto F., Gigli G.L. Sleep abnormalities in mentally retarded autistic subjects: Down's syndrome with mental retardation and normal subjects. Brain Dev. 21:1999;548-553
15. Dzoljic E., Van Leeuwen R., De Vries R., Dzolic M.R. Vigilance and EEG power in rats: effects of potent inhibitors of the neuronal nitric oxide synthase. Naunyn-Schmiedeberg's Arch. Pharmacol. 356:1997;56-61
16. Epstein C.J. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The Metabolic and Molecular Basis of Inherited Disease. 1995;749-794 McGraw Hill Press, New York
17. Epstein C.J., Avraham K., Lovett M., Smith S., Elroy-Stein O., Rotman G., Bry C., Groner Y. Transgenic mice with increased Cu/Zn superoxide dismutase activity: animal model of dosage effects in Down syndrome. Proc. Natl. Acad. Sci. U. S. A. 84:1987;8044-8048
18. Franken P., Malafosse A., Tafti M. Genetic determinants of sleep regulation in inbred mice. Sleep. 22:1999;155-169
19. Franken P., Chollet D., Tafti M. The homeostatic regulation of sleep need is under genetic control. J. Neurosci. 21:2001;2610-2621
20. Gahtan E., Auerbach J.M., Groner Y., Segal M. Reversible impairment of long-term potentiation in transgenic Cu/Zn-SOD mice. Eur. J. Neurosci. 10:1998;538-544
21. Galdzicki Z., Siarey R.J. Understanding mental retardation in Down's syndrome using trisomy 16 mouse models. Genes, Brain Behav. 2:2003;167-178
22. Graves L., Pack A., Abel T. Sleep and memory: a molecular perspective. Trends Neurosci. 24:2001;237-243
23. 15N] in biological fluids. Anal. Biochem. 126:1982;131-138
24. Groner Y., Lieman-Hurwitz J., Dafni N., Sherman L., Levanon D., Bernstein Y., Danciger E., Elroy-Stein O. Molecular structure and expression of the gene locus on chromosome 21 encoding the Cu/Zn superoxide dismutase and its relevance to Down syndrome. Ann. N.Y. Acad. Sci. 450:1985;133-156
25. Grubar J.C., Gigli G.L., Colognola R.M., Ferri R., Musumeci S.A., Bergonzi P. Sleep patterns of Down's syndrome children: effects of butoctamide hydrogen succinate (BAHS) administration. Psychopharmacology. 90:1986;119-122
26. Head E., Azizeh B.Y., Lott I.T., Tenner A.J., Cotman C.W., Cribbs D.H. Complement association with neurons and beta-amyloid deposition in the brains of aged individuals with Down syndrome. Neurobiol. Dis. 8:2001;252-265
27. Heneka M., Wiesinger H., Dumitrescu-Ozimek L., Riederer P., Feinstein D., Klockgether T. Neuronal and glial coexpression of arginosuccinate synthetase and inducible nitric oxide synthase in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60:2001;906-916
28. Hsiao K. Transgenic mice overexpressing Alzheimer amyloid precursor proteins. Exp. Gerontol. 33:1998;883-889
29. Hsiao K., Borchelt D., Olson K., Johannsdottir R., Kitt C., Yunis W., Xu S., Eckman C., Tounkin S., Price D., Iadecola C., Clark B., Carlson G. Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron. 15:1995;1203-1218
30. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Aβ elevation and amyloid plaques in transgenic mice. Science. 274:1996;99-102
31. Huber R., Deboer T., Tobler I. Effects of sleep deprivation on sleep and sleep EEG in three mouse strains: empirical data and simulations. Brain Res. 857:2000;8-19
32. Huerta J.J., Llamosas M.M., Cernuda-Cernuda R., Garcia-Fernandez J.M. Spatial-temporal analysis of light-induced Fos expression in the retina of rd mutant mice. Brain. Res. 834:1999;122-127
33. Huitron-Reséndiz S., Sanchez-Alavez M., Gallegos P., Berg G., Crawford E., Guacchino J.L., Games D., Henriksen S.J., Criado J.R. Age-independent and age-related deficits in visuospatial learning, sleep-wake states, thermoregulation and motor activity in PDAPP mice. Brain Res. 928:2002;126-137
34. Iadecola C., Zhang F., Niwa K., Eckman C., Turner S.K., Fischer E., Younkin S., Borchelt D.R., Hsiao K.K., Carlson G.A. SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat. Neurosc. 2(2):1999;157-161
35. Isacson O., Seo H., Lin L., Albeck D., Granholm A.C. Alzheimer's disease and Down's syndrome: roles of APP, trophic factors and ACh. Trends Neurosci. 25:2002;79-84
36. Jaarsma D., Haasdijk E., Grashorn J., Hawkins R., van Duijn W., Verspaget H., London J., Holstege J. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degenerescence, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1. Neurobiol. Dis. 7:2000;623-643
37. Kapas L., Fang J., Krueger J.M. Inhibition of nitric oxide synthesis inhibits rat sleep. Brain Res. 664:1994;184-196
38. Kim S., Lee S., Ryu S., Suk J., Park C. Comparative analysis of the anxiety-related behaviors in four inbred mice. Behav. Processes. 60:2002;181-190
39. Kola I., Herzog P.J. Down syndrome and mouse models. Curr. Opin. Genet. Dev. 8:1998;316-321
40. Lejeune J., Gautier M., Turpin R. Etude des chromosomes somatiques de neuf enfants mongoliens. C. R. Acad. Sci. 248:1959;1722-1724
41. Leung L.G. Generation of θ and γ rhythms in the hippocampus. Neurosci. Biobehav. Rev. 22:1998;275-290
42. Levanon A., Tarasiuk A., Tal A. Sleep characteristics in children with Down syndrome. J. Pediatr. 134:1999;755-760
43. Lott I.T., Head E. Down syndrome and Alzheimer's disease: a link between development and aging. Ment. Retard. Dev. Disabil. Res. Rev. 7:2001;172-178
44. Mineur Y.S., Crusio W.E. Behavioral and neuroanatomical characterization of FVB/N inbred mice. Brain Res. Bull. 57:2002;41-47
45. Mrosovsky N., Hampton R.R. Spatial responses to light in mice with severe retinal degeneration. Neurosci. Lett. 222:1997;204-206
46. Nabarra B., Casanova M., Paris D., Nicole A., Toyama K., Sinet P.M., Ceballos I., London J. Transgenic mice overexpressing the human Cu/Zn-SOD gene: ultrastructure studies of a premature thymic involution model of Down's syndrome (trisomy 21). Lab. Invest. 74:1996;617-626
47. Pace-Schott E., Hobson J. The neurobiology of sleep: genetics, cellular physiology and subcortical networks. Nat. Rev. Neurosci. 3:2002;591-605
48. Paris D., Toyama K., Magarbane A., Casanova M., Sinet P.M., London J. Rapid fluorescence in situ hybridation on interphasic nuclei to discriminate between homozygous and heterozygous transgenic mice. Transgenic Res. 5:1996;397-403
49. Pearlman C., Greenberg R. Brief REM sleep deprivation impair consolidation in complex learning in rats. Psychophysiology. 9:1972;109-110
50. Przedborski S., Kostic V., Jackson-Lewis V., Naini A.B., Simonetti S., Fahn S., Carlson E., Epstein C.J., Cadet J.L. Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced neurotoxicity. J. Neurosci. 12:1992;1658-1667
51. Sago H., Carlson E.J., Smith D.J., Rubin E.M., Crnic L.S., Huang T.T., Epstein C.J. Genetic dissection of region associated with behavioral abnormalities in mouse models for Down syndrome. Pediatr. Res. 48:2000;606-615
52. Sakai K. Executive mechanisms of paradoxical sleep. Arch. Ital. Biol. 126:1988;239-257
53. Schickler M., Knobler H., Avraham K.B., Elroy-Stein O., Groner Y. Diminished serotonin uptake in platelets of transgenic mice with increased Cu/Zn-superoxide dismutase activity. EMBO. 8:1989;1385-1392
54. Sinet P.M., Lavelle F., Michelson A.M., Jerome H. Superoxide dismutase activities of blood platelets in trisomy 21. Biochem. Biophys. Res. Commun. 67:1975;904-909
55. Tobler I. Is sleep fundamentally different between mammalian species? Behav. Brain Res. 69:1995;35-41
56. Tobler I. Phylogeny of sleep regulation. Kryger M.H., Roth T., Dement W.C. Principles and Practice of Sleep Medecine. 2000;72-81 Saunders, Philadelphia
57. Toth L.A., Verhulst S.J. Strain differences in sleep patterns of healthy and influenza-injected inbred mice. Behav. Genet. 33:2003;325-336
58. Ursin R. Serotonin and sleep. Sleep Med. Rev. 6:2002;57-69
59. Voikar V., Koks S., Vasar E., Rauvala H. Strain and gender differences in the behavior of mouse lines commonly used in transgenic studies. Physiol. Behav. 72:2001;271-281
60. Wisniewski H.M., Rabe A. Discrepancy between Alzheimer-type neuropathology and dementia in persons with Down's syndrome. Ann. N.Y. Acad. Sci. 477:1985;247-260